SAB Biotherapeutics Inc (SABS)
4.03
+0.01
(+0.25%)
USD |
NASDAQ |
May 03, 16:00
SAB Biotherapeutics Market Cap: 37.18M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 37.18M |
| May 02, 2024 | 37.09M |
| May 01, 2024 | 37.82M |
| April 30, 2024 | 39.58M |
| April 29, 2024 | 38.65M |
| April 26, 2024 | 39.21M |
| April 25, 2024 | 36.99M |
| April 24, 2024 | 40.59M |
| April 23, 2024 | 40.22M |
| April 22, 2024 | 40.50M |
| April 19, 2024 | 39.58M |
| April 18, 2024 | 41.15M |
| April 17, 2024 | 42.44M |
| April 16, 2024 | 45.02M |
| April 15, 2024 | 42.53M |
| April 12, 2024 | 43.13M |
| April 11, 2024 | 41.98M |
| April 10, 2024 | 41.98M |
| April 09, 2024 | 41.15M |
| April 08, 2024 | 41.15M |
| April 05, 2024 | 40.04M |
| April 04, 2024 | 40.78M |
| April 03, 2024 | 41.15M |
| April 02, 2024 | 41.51M |
| April 01, 2024 | 39.58M |
| Date | Value |
|---|---|
| March 28, 2024 | 41.88M |
| March 27, 2024 | 38.93M |
| March 26, 2024 | 38.47M |
| March 25, 2024 | 39.21M |
| March 22, 2024 | 45.02M |
| March 21, 2024 | 43.27M |
| March 20, 2024 | 44.19M |
| March 19, 2024 | 44.28M |
| March 18, 2024 | 49.82M |
| March 15, 2024 | 50.92M |
| March 14, 2024 | 55.35M |
| March 13, 2024 | 53.41M |
| March 12, 2024 | 54.06M |
| March 11, 2024 | 50.65M |
| March 08, 2024 | 49.45M |
| March 07, 2024 | 49.08M |
| March 06, 2024 | 48.80M |
| March 05, 2024 | 46.03M |
| March 04, 2024 | 40.13M |
| March 01, 2024 | 40.68M |
| February 29, 2024 | 41.14M |
| February 28, 2024 | 38.93M |
| February 27, 2024 | 46.12M |
| February 26, 2024 | 46.03M |
| February 23, 2024 | 45.76M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
19.15M
Minimum
Apr 12 2023
488.66M
Maximum
Dec 01 2021
89.80M
Average
46.47M
Median
Jul 29 2022
Market Cap Benchmarks
| CEL-SCI Corp | 87.99M |
| AIM ImmunoTech Inc | 20.20M |
| IGC Pharma Inc | 32.58M |
| NovaBay Pharmaceuticals Inc | 2.856M |
| Protalix BioTherapeutics Inc | 83.28M |
Market Cap Related Metrics
| Price to Book Value | 0.6489 |
| Price | 4.03 |
| Earnings Yield | -192.1% |